查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球蛋白质标记市场
市场调查报告书
商品编码
1176603

2023-2030 年全球蛋白质标记市场

Global Protein Labeling Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2023-2030)，全球蛋白质标记市场规模预计将以 6.4% 的复合年增长率增长。

生物学研究需要使用与目标蛋白质共价结合的分子信标，以促进标记蛋白质及其结合伙伴的纯化或检测。 蛋白质标记的主要目标是监测生物过程、化合物的可靠定量、多重样品中蛋白质修饰和亚型的特异性检测、提高检测灵敏度以及简化检测工作流程。。

市场动态

推动全球蛋白质标记市场发展的主要因素是全球慢性病患病率上升、研发成本上升以及生物技术技术的采用。 越来越多的新产品发布正在促进蛋白质标记市场的增长。

基因组测序、蛋白质组学研究的兴起以及先进生物工程技术的采用有望推动市场增长。

越来越多地采用这些蛋白质标记产品进行生物学和正常细胞功能研究中的翻译后修饰研究，越来越多地采用先进的生物工程技术在各种技术中，例如癌症慢性病的流行和诊断需求的增加正在推动蛋白质标记市场。 世界上慢性病的增加也推动了市场的增长。 此外，许多医疗保健公司正在加紧研发活动以开发新产品。

蛋白质印迹、ELISA、免疫组织化学、免疫细胞化学和流式细胞术等检测方法需要用于医学和临床研究的各种蛋白质标记方法。 市场上有多种标籤供多种用途使用，每次使用时都应仔细选择要使用的名称类型和标籤策略。 对基因组测序和蛋白质组学研究的需求激增正在推动市场增长。 此外，主要参与者对新型疫苗和技术先进产品的研究和开发不断增加，预计也将在市场增长中发挥重要作用。

各种新产品的发布、监管批准和研究都为市场的增长做出了贡献。 例如，2021年9月17日，PerkinElmer宣布已完成对生命科学试剂和抗体供应商BioLegend的收购，总收购价格约为52.5亿美元。 此次收购将 PerkinElmer 的生命科学业务扩展到高增长领域，如蛋白质组学、细胞计数、多重分析、磁性细胞分离、重组蛋白和生物加工。

预计熟练专业人员的数量有限会阻碍市场的增长。

然而，在当前情况下，熟练专业人员的可用性有限、主要参与者之间为推出先进产品而展开的竞争加剧以及产品的使用有限可能会阻碍市场增长。

此外，蛋白标记的高成本也是抑制生长的一大因素。 化学标记的缺点是修饰的蛋白质失去了一种或多种活性。 因此，应针对未标记的蛋白质测试标记蛋白质的活性。 此外，代谢标记需要纯化放射性蛋白，长期使用低温恆温器和离心机使得难以建立放射性。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID 患者的增加，各种研究和临床试验被推迟，蛋白质标记市场因 COVID 遭受了巨大损失。 世界各地正在发生各种举措、产品发布、创新、合作和合併，推动了市场的增长。 例如，2021年7月28日，Promega公司宣布美国FDA批准了Promega OncoMate MSI Dx分析系统。 美国病理学家和肿瘤学家可以使用微卫星不稳定性 (MSI) 诊断来筛查结直肠癌患者是否患有 Lynch 综合征。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 基因组测序和蛋白质组学研究的兴起
      • 更多地采用先进的生物工程技术
    • 约束因素
      • 缺乏熟练的专业人员
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 工具包
  • 试剂
    • 探测标籤
    • □
    • 生物素
    • 其他
  • 服务

第 8 章按符号类型

  • 体外标籤
  • 体内标记
  • 生物正交标记

第 9 章按应用

  • 基于细胞的分析
  • 免疫技术
  • 蛋白质微阵列
  • 质谱
  • 荧光显微镜

第 10 章最终用户

  • 医院
  • 研究所
  • 诊断中心
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第13章公司简介

  • Thermo Fisher Scientific
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Merck KGaA
  • PerkinElmer Inc.
  • GE Healthcare
  • Qiagen N.V.
  • New England Biolabs
  • SeraCare Life Sciences Inc.
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies

第14章 DataM

简介目录
Product Code: DMBT820

Market Overview

The global protein labeling market size was valued at US$ XX mill-ion in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.4% during the forecast period (2023-2030).

Biological research requires the use of molecular labels that are covalently attached to a protein of interest to facilitate the purification or detection of the labeled protein and its binding partners. The primary purpose of protein labeling is monitoring the biological process, reliable quantification of compounds, specific detection of protein modifications and isoforms in multiplexed samples, enhancement of detection sensitivity, and simplification of detection workflows.

Market Dynamics

The major factors driving the global protein labeling market are an increase in the number of chronic diseases globally, rising research and development expenditure and the adoption of bioengineering techniques. An increase in novel product launches contributes to the growth of the protein labeling market.

The rising genome sequencing and proteomics research and adoption of sophisticated bioengineering techniques are expected to drive the market's growth.

The rising adoption of these protein labeling products for post-translational modification studies in the investigation of biological functions as well as normal cell functioning, the rising adoption of sophisticated bioengineering techniques in various technologies, and the growth in the prevalence of chronic diseases such as cancer and the need for diagnosis drive the protein labeling market. An increase in chronic diseases globally is also aiding market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Test that includes western blotting, ELISA, immunohistochemistry, immunocytochemistry, and flow cytometry requires protein labeling methods for various medical and clinical studies. There is an availability of multiple labels in the market for multiple applications, and the type of name and labeling strategy used must be carefully selected for each application. The surge in demand for genome sequencing and proteomics research is fueling the market's growth. Moreover, the increase in research and development of novel vaccines and the availability of technologically advanced products by key players are also expected to play a vital role in the market's growth.

Various novel product launches, regulatory approvals and research studies contribute to the market's growth. For instance, in September 17, 2021, PerkinElmer, Inc. announced its completion of the acquisition of BioLegend, a life science reagents and antibodies provider, for approximately $5.25 billion in total consideration. This acquisition expands the life science franchise of PerkinElmer into high-growth areas like proteogenomics, cytometry, multiplex assays, magnetic cell separation, recombinant proteins and bioprocessing.

The skillful professional's limited availability is expected to hamper the market's growth.

However, the limited availability of skillful professionals in the current scenario, increased competition among key players for launching advanced products, and limited product applications may hinder the growth of the market.

The high cost of protein labeling is also a leading factor for restrained growth, as chemical labeling has a drawback that the protein that has been modified can lose one or more activities. So, the labeled protein's activity should be tested relative to unlabeled protein. Metabolic labeling also needs purification of the radioactive protein, and over the extended use of cold room equipment and centrifuges, it is difficult to consist the radioactivity.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The protein labeling market has experienced huge losses due to COVID, as various research and clinical trials got postponed due to the increasing number of COVID cases. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 28, 2021, Promega Corporation announced that U.S. FDA had cleared its Promega OncoMate MSI Dx Analysis System. Pathologists and oncologists in the US can utilize microsatellite instability (MSI) diagnostic for screening Lynch syndrome in colorectal cancer patients.

Segment Analysis

The reagent segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The reagent segment is the highest market holder in the global protein labeling market. The global protein labeling market is segmented based on product type as kits, reagents and services. The reagents segment is the largest market shareholder due to its high demand and usage, increasing prevalence of cancer and rising adoption of these for protein labeling products. Reagents are further sub-segmented into probes, biotin, proteins, enzymes and others. These reagents hold the largest market share due to increased demand for peptide-binding agents and increased research and development activities, which are expected to remain high during the forecast period.

The protein labeling reagents are developed to label target proteins selectively. These products are classic dyes, biotinylation reagents, radioisotope labels, fluorescent labels, assays, molecular probes, and labeling kits. Fluorophores, stable isotopes, and mass tags are three important tags implemented during protein labeling. Western blotting, immunohistochemistry, ELISA, immunocytochemistry, and flow cytometry require protein labeling methods for various medical and clinical studies. There is an availability of multiple labels in the market for multiple applications, and the type of name and labeling strategy used must be carefully selected for each application.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in July 28, 2021, PerkinElmer, Inc announced the launch of its four-novel ready-to-use AlphaLISA KRAS kits, developed to provide scientists with a better understanding of complex KRAS protein structures as well as mutations so that potential new therapeutic candidates identification gets more easy, precise and quick for a broad range of prevalent cancers.

Geographical Analysis

North America holds the largest market share in the global protein labeling market.

North America dominates the global protein labeling market, primarily due to its large population, excellent medical infrastructure, and rising number of chronic diseases like cancer. The market is expected to grow at a relatively high pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of products for various applications, including cell-based assay, immunological techniques, mass spectroscopy, protein microarrays, fluorescence microscopy, increase in pharmaceutical establishment across the region, government approvals, and key players in the region are contributing to the growth of the protein labeling market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, regulatory approvals, technological advancements, collaborations, and agreements are taking place in this region. For instance, in January 11, 2022, Merck, a science and technology company, announced its Stable Isotope Center of Excellence expansion in Miamisburg, Ohio. The expansion strengthens the continued commitment of the company to this product category, which shows growing utility in industrial, diagnostic and research applications.

Competitive Landscape

The protein labeling market is moderately competitive with local and global companies' presence. Thermo Fisher Scientific, Merck KGaA, PerkinElmer Inc., GE Healthcare, Qiagen N.V., New England Biolabs, SeraCare Life Sciences Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 7, 2021, Thermo Fisher Scientific announced its agreement with Advanced Electrophoresis Solutions Ltd (AES), protein imaging technologies specialists, to combine mass spectrometry (MS) with essential protein separation techniques for the advancement of therapeutic protein development via streamlined characterization.

Thermo Fisher Scientific.

Overview: This is a company that supplies a variety of scientific or analytical instruments, lab reagents & consumables, and some scientific software services. It was founded in 1956 and headquartered in Waltham, Massachusetts, U.S.

Product Portfolio:

Fluorescent Protein Labeling Kits: The fluorescent dye attachment to proteins or other biomolecules is a general strategy used to better understand protein function and structure. These fluorescent proteins can be utilized in various applications, like immunochemistry, receptor labeling, cell tracing and fluorescence spectroscopy.

Key Developments: In October 31, 2022, Thermo Fisher Scientific Inc. announced entering into a definitive acquisition agreement with The Binding Site Group, a specialty diagnostics company that provides specialized diagnostic instruments and assays, from a group of shareholders led by Nordic Capital, a European private equity firm.

The global protein labeling market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising genome sequencing and proteomics research
      • 4.1.1.2. Increasing adoption of sophisticated bioengineering techniques
    • 4.1.2. Restraints:
      • 4.1.2.1. Limited availability of skillful professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Kits *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Reagents
    • 7.3.1. Probes/ Tags
    • 7.3.2. Enzyme
    • 7.3.3. Biotin
    • 7.3.4. Others
  • 7.4. Services

8. By Labeling Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 8.1.2. Market Attractiveness Index, By Labeling Type
  • 8.2. In-Vitro Labeling *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. In-Vivo Labeling
  • 8.4. Bio-orthogonal Labeling

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Cell-Based Assay *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Immunological Techniques
  • 9.4. Protein Microarrays
  • 9.5. Mass Spectroscopy
  • 9.6. Fluorescence Microscopy

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Research laboratories
  • 10.4. Diagnostic centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Labeling Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Thermo Fisher Scientific *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Merck KGaA
  • 13.3. PerkinElmer Inc.
  • 13.4. GE Healthcare
  • 13.5. Qiagen N.V.
  • 13.6. New England Biolabs
  • 13.7. SeraCare Life Sciences Inc.
  • 13.8. Promega Corporation
  • 13.9. Bio-Rad Laboratories, Inc.
  • 13.10. Agilent Technologies

LIST NOT EXHAUSTIVE

14. Global Protein Labeling Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and End-User
  • 14.3. Contact Us